Discounted Drugs for Clinical Trials Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 7, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Apr 7, 2022
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Discounted Drugs for Clinical Trials Act
This bill allows researchers to obtain certain high-cost drugs and biologics at discounted prices from manufacturers. Researchers must apply to the Food and Drug Administration for approval; manufacturers must sell the approved quantity of drugs to researchers at the discounted price and are subject to civil actions from researchers for noncompliance.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related & companion bills
2
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
1
Cite this page
U.S. Congress. (2026). S. 4053: Discounted Drugs for Clinical Trials Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-4053/
"S. 4053: Discounted Drugs for Clinical Trials Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-4053/.
S. 4053, 117th Cong. (2026), https://openamerica.io/bill/117-S-4053/.
[S. 4053: Discounted Drugs for Clinical Trials Act](https://openamerica.io/bill/117-S-4053/)